No photo of Debra Anne Goldstein

View Scopus Profile

Debra Anne Goldstein

  • 4463 Citations
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Ophthalmology

Training Experience

1989Residency, McGill University School of Medicine, Canada
1993Residency, McGill University School of Medicine, Canada
1995Fellowship, University of Illinois at Chicago

Education/Academic qualification

MD, McGill University

… → 1988

Fingerprint Dive into the research topics where Debra Anne Goldstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Efficacy of weekly adalimumab in patients with noninfectious uveitis

Goldstein, D. A.

Illinois Society for the Prevention of Blindness

7/1/19 → 6/30/20

Project: Research project

    • Prot #GS-US-432-4097: A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis

    Goldstein, D. A. & Koreishi, A. F.

    PPD Development, Gilead Sciences, Inc.

    10/24/17 → 10/24/20

    Project: Research project

    Prot #PSV-FAI-001: A PHASE III, MULTI-NATIONAL, MULTI-CENTER, RANDOMIZED, MASKED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A FLUOCINOLONE ACETONIDE INTRAVITREAL (FAI) INSERT IN SUBJECTS WITH CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT O

    Goldstein, D. A.

    PPD Development, pSivida Corp.

    3/26/14 → 3/26/20

    Project: Research project

    Prot #CLS1001-301: PEACHTREE: A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects with Macular Edema associated with Non-Infectio

    Goldstein, D. A. & Koreishi, A. F.

    Chiltern International, Inc., Clearside Biomedical, Inc.

    4/29/16 → 10/31/19

    Project: Research project

    Prot #X052132: An Open-Label, Non-Randomized, Single-Arm, Rollover Study to Continue Dosing of Gevokizumab in Subjects with Non Infectious Intermediate-, Posterior-, or Pan-Uveitis Who Each Successfully Completed Either the X052130 or the X052131 Study or

    Goldstein, D. A.

    XOMA (US) LLC

    3/6/15 → 3/6/18

    Project: Research project

    Research Output

    Novel imaging modalities in patients with uveitis

    Deák, G. G., Zhou, M., Sporysheva, A. & Goldstein, D. A., Feb 2020, In : Canadian Journal of Ophthalmology. 55, 1, p. 20-29 10 p.

    Research output: Contribution to journal › Review article

    • Atypical herpes simplex virus type 2 acute retinal necrosis presentation with large subretinal lesion

    Wang, D., Bloomberg, J. D., Sobrin, L., Goldstein, D. & Skondra, D., Sep 2019, In : American Journal of Ophthalmology Case Reports. 15, 100501.

    Research output: Contribution to journal › Article

    Open Access

    • Moving from Syndromic Description to Etiologic Diagnosis for Uveitis

    Leveque, T. K. & Goldstein, D. A., Apr 1 2019, In : JAMA ophthalmology. 137, 4, p. 438-439 2 p.

    Research output: Contribution to journal › Review article

    Must beg to differ

    Albini, T., Callaway, N. F., Jaffe, G. J., Feuer, W., Davis, J., Goldstein, D., Lowder, C., Lin, P., Nguyen, Q., Srivastava, S., Callanan, D., Galor, A., Goldhardt, R. & Flynn, H., Jan 1 2019, In : Ophthalmic Surgery Lasers and Imaging Retina. 50, 5, p. 266-268 3 p.

    Research output: Contribution to journal › Review article

    • Partial scleral rupture presenting 4 years after laser in situ keratomileusis

    Lamattina, K. C., Feder, R. S., Koreishi, A. F. & Goldstein, D. A., Apr 1 2019, In : Cornea. 38, 4, p. 498-501 4 p.

    Research output: Contribution to journal › Article